TLR4 and chronic obstructive pulmonary disease: By inhibiting the abnormal activation of the TLR4/MyD88 pathway, cyclic peptide extracts can reduce lung inflammation, increase alveolar space, improve inflammatory cell infiltration, and improve pulmonary ventilation function in COPD model rats.64